Lab Automation Market to Hit USD 7.71 Billion by 2029 with 6.9% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Dec. 18, 2024 /PRNewswire/ — The global lab automation market is expected to reach USD 7.71 Billion by 2029 from USD 5.85 Billion in 2024, growing at a CAGR of 6.9 % during the forecast period. The major driving forces of the lab automation market comprise rising needs for high-throughput screening and a lack of proficient laboratory personnel. Automation can help laboratories increase efficacy as it provides accurate results with lower cost control in operations. This major development in automation involves AI, robotics, and machine learning. Other factors affecting this market include increasing cases of chronic diseases and a rise in the demand for personalized medicine. The adoption of automation increases the handling of large samples of clinical patients, thus helping in faster and more precise diagnosis.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158
Browse in-depth TOC on “Lab Automation Market“
320 – Tables
60 – Figures
245 – Pages
Automated workstations accounted for the largest share of the Lab Automation market.
The highest market share in laboratory automation is covered by workstations that automate repetitive and long-duration tasks in laboratories. It also increases throughput and improves reproducibility when it comes to research diagnostics and drug development. Nowadays, the demand for accuracy in data and quick results makes automated workstations appealing. Some of the world’s leading companies that supply advanced automated workstations include Thermo Fisher Scientific Inc. (US), Hamilton Company (US), PerkinElmer (US), Beckman Coulter (US), and Tecan Group (Switzerland). Such automated workstations serve various applications- sample preparation, liquid handling, and assay setup- among others. They significantly support research in any domain such as clinical, pharmaceutical, and biotechnology.
By application, drug discovery accounts for the largest share in 2023.
Applications associated with drug discovery account for the largest share of the lab automation market. With automation technologies, the various stages of compound testing and high-throughput screening can be simplified. This increases the efficiency of finding drug candidates but also substantially saves on labour costs. With an increasing requirement for newer therapeutics across various fields, comprising oncology, neurology, and infectious diseases, the lab automation market will continue to be dominated by automated solutions in drug discovery.
By end user hospitals & diagnostic laboratories account for the largest share in 2023.
the high-throughput, efficient automation solutions address the growing needs of the healthcare sector. The market for lab automation primarily targets hospital and diagnostic laboratories. The increasing prevalence of chronic diseases, outbreaks of infectious diseases, and the pressure for rapid diagnosis have necessitated these labs to implement automation in their systems so that they can ensure speedy diagnostic procedures, accurate results, and reduced human error. Automation in technologies includes sample handling systems, liquid processing, and data management to handle many tests. The prominent players in automation solutions are Roche (Switzerland), Siemens Healthineers (Germany), Abbott Laboratories (US), and Beckman Coulter (US).
North America dominates the Laboratory Automation market in 2023.
North America has the largest market share with strong healthcare infrastructure, rapid acceptance of innovative technology, and investment in R&D. There is a requirement for chronic disease diagnosis due to increased disease prevalence that has increased the application of automation in hospitals, diagnostic labs, and research centers. The leading companies from North America, including Thermo Fisher Scientific Inc., Beckman Coulter, Agilent Technologies, and PerkinElmer. With further innovation and supporting regulatory frameworks, North America is likely to hold a strong position in the market for lab automation.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=1158
The lab automation market is highly competitive with continuous innovation. A few of the competitive factors include the development of automated high-throughput systems, artificial intelligence/data analytics integration, and increased accuracy, reliability, and speed. Additionally, companies are investing majorly in research and development for their products to develop and maintain their competitive edge, and therefore, this lab automation market is constantly growing. The leaders of the market in this space are continuously broadening their product lines to suit the evolving needs of the laboratories in the sectors, such as diagnostics, pharmaceuticals, and biotechnology. Here are some of the key players in the Lab automation market: Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomérieux (France), Hamilton Company (US), Hudson Robotics (US).
Thermo Fisher Scientific, Inc. (US): Thermo Fisher Scientific is a well-known player in the lab automation market and is known for offering analytical equipment, reagents & consumables, laboratory equipment, and software & services. The firm has a global presence in over 50 countries North America, Europe, APAC, and Latin America. The firm offers lab automation products such as automated liquid handling systems, automated ELISA Systems, automated nucleic acid extraction kits, laboratory robot systems & mobile robots, laboratory data management solutions, microplate readers, multidrop dispensers, and microplate washers. These products are provided through the Analytical Instruments and Laboratory Products & Biopharma Services segment. The firm engages in strategic acquisition to mark its presence in the market. For instance, it recently acquired Olink Holding AB (Sweden) in October 2023, to grow in the proteomics sector.
Tecan Group (Switzerland): Tecan Group leads the lab automation market and is developing robotic sample processors, detection devices, laser scanners, integrated systems, and pumps and valves for high-precision liquid handling. The firm has manufacturing and R&D sites in North America and Europe and operates its services in over 52 countries. The core products offered include microplate readers & washers, liquid handling & automation products, robotic arms, nucleic acid purification systems, automated ELISA systems, and software. The company works through two business segments-Life Sciences Business and Partnering Business. One of the recent developments includes launching Resolvex i1300 (a component of Fluent automation workstation) in February 2024, which supports proteomics workflows. This product may be applied in biomarker discovery, drug development, and personalized medicine applications.
Danaher Corporation (US): Danaher Corporation is the laboratory automation market major in designing, developing, and marketing medical, industrial, and commercial products. The firm has 93 sites in the US and 119 sites in 30 other countries. The lab automation products include microplate readers, DNA Extraction Kits, liquid handlers, Clinical Laboratory Diagnostic Products, and software. These are offered through the life sciences business segment. In August 2024, the company acquired Genedate (Switzerland) to include Genedata’s life sciences software solutions in its product portfolio.
Agilent Technologies (US): This firm is involved in designing, manufacturing, and delivering products and services within its diagnostics, life sciences, and applied chemicals divisions. With operations worldwide across the Americas; Europe; the Middle East and Africa; and Asia/Pacific, this global company has its manufacturing and research and development sites in Australia, China, Germany, Italy, Malaysia, Singapore, the UK, and the US. The lab automation products offered by this firm include automated Liquid Handling Platforms, Microplate Readers, Microplate Washers & Dispensers, Microplate Stackers & Incubators, Microplate Automation Software, and Software & Informatics. Under its business segment Life Sciences and Applied Markets, Agilent offers lab automation products. In January 2024, Agilent launched ProteoAnalyzer, which is an automated parallel capillary electrophoresis of proteomics.
F. Hoffmann-LA Roche Ltd. (Switzerland): It is a leading player in the lab automation market, with global presence across North America, Europe, Latin America, Africa, and Asia for Roche. The firm operates through two business segments-Pharmaceuticals and Diagnostics. This firm delivers workflow solutions and lab automation solutions under the Diagnostics segment. Some of the products included in its portfolio are Cobas P 312 Preanalytical System, Cobas mobile solution, Cobas P 501/Cobas P 701 Postanalytical Units, and Cobas P 512 Preanalytical System.
For more information, Inquire Now!
Related Reports:
Artificial Intelligence in Medical Diagnostics Market
Artificial Intelligence in Genomics Market
Get access to the latest updates on Lab Automation Companies and Lab Automation Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://healthtechnologynet.com/wp-content/uploads/2024/12/MarketsandMarkets-3.jpg
View original content:https://www.prnewswire.com/news-releases/lab-automation-market-to-hit-usd-7-71-billion-by-2029-with-6-9-cagr–marketsandmarkets-302334552.html
SOURCE MarketsandMarkets
